this pattern of disease progression was not influenced by treatment type ( i.e . endocrine or cytotoxic ) , tumour response to treatment , oestrogen receptor status , prior adjuvant cytotoxic treatment , or disease free interval .
C0027651
tumour
C0012634
disease